Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synera in myofascial trigger point pain
NCT01106989Phase 2Completed
- Sponsor
- ZARS Pharmaceuticals
- Start
- Jun 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracaine in myofascial pain syndrome (MPS), sponsored by ZARS Pharmaceuticals. Started Jun 2010; status: completed.
02
Drugs
tetracaine
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT01106989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106989.